18 and older, any sex, with Medication Adherence. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Medication Adherence at Baseline and 6-month Follow-up PeriodPrimary· Baseline and at 6 months
The participant's cancer medication adherence was taken at baseline and within a 6-month follow-up period. We measured the participant's self-efficacy with medication adherence increase with their OCAs using the SEAMS scale.
SEAMS Scale: 21 items scale, ranges from 21-63, higher scores indicate higher level of self-efficacy for medication adherence.
Group
Value
95% CI
Nurse Coach Intervention
59.4
± 5.18
Control
55.95
± 9.34
Health Literacy at Baseline and 6-month Follow-up PeriodSecondary· Baseline and at 6 months
We measured the participant's cancer health literacy at baseline and at 6 months via the CHLT-30.
The CHLT-30 measures cancer health literacy along a continuum with 0-30 representing the number of correct answers provided to the items. Continuous scores provided by the CHLT-30 do not allow to determine who has limited health literacy or put people in a category, with higher scores indicating a higher degree of cancer health literacy.
Group
Value
95% CI
Nurse Coach Intervention
22.95
± 4.62
Control
23.32
± 8.36
Sponsor's own description
Oral chemotherapeutic agents (OCAs) are increasingly being used as an alternative to traditional intravenous chemotherapy, and factors promoting this trend include increased survival times requiring long-term therapy, acceptability among patients, convenience, and cost savings due to reduced hospital time. Although OCAs are commonly preferred by patients, adherence to these medications vary. Suboptimal medication adherence leads to loss of treatment efficacy, increased toxicity, and increased health care costs. Thus, it is critical to develop and test interventions that effectively improve adherence to OCAs. Although the medication adherence literature has been criticized for methodological issues, some components of interventions have had promising results on adherence such as electronic monitored adherence feedback, cognitive-education, nurse-based interventions, and technology-based or telehealth strategies. The investigators propose to unify components of these effective approaches in a novel way to assess the efficacy and feasibility of two telehealth-based strategies (electronic medication-event monitoring with feedback and tailored nurse coaching which includes cognitive-education) in an effort increase OCA adherence among cancer patients who are at high-risk for non-adherence in rural eastern North Carolina.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07420634 — Multilevel Ecological and COM-B Determinants of Medication Adherence in Adults With Diabetes
· recruiting
NCT06876233 — Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication
· NA
· recruiting
NCT05624931 — Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa
· NA
· recruiting
NCT06949774 — INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)
· NA
· recruiting
NCT06569290 — Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Sci
· NA
· active not recruiting
Other East Carolina University trials
Trials by the same sponsor.
NCT07390760 — Remote Ischemic Conditioning and Spinal Reflex Modulation in Children With Cerebral Palsy
· NA
· recruiting
NCT07525193 — PREnatal Choline and Infant Outcomes Study
· NA
· recruiting
NCT06860464 — Remote Ischemic Conditioning and Spinal Reflex Modulation
· NA
· enrolling by invitation
NCT06420193 — Evaluating Procedures for a Study of the AYA Survivors Coping and Emotional Needs Toolkit
· NA
· completed
NCT06319014 — Physical Activity to Mitigate PreEclampsia Risk
· NA
· recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by East Carolina University
Last refreshed: 22 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02543723.